Prostate Cancer Market is expected to reach US$ 24.7 billion by 2033 | FMI

The Global Prostate Cancer Market is expected to be worth around US$ 10.92 billion in 2023 and to grow at an 8.5% CAGR through 2033. By 2033, the market is expected to be worth US$ 24.7 billion . Recent developments in drug development, an increasing number of drugs that have been approved by the FDA, …

Age Related Vision Dysfunction Market is expected to reach valuation of US$ 130 Billion by 2033

A recently published study by FMI expects the global Age-Related Vision Dysfunction Market to augment at a 3.7% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 130 Billion is expected for the market. The rising incidence of visual impairment and blindness is a primary driver of …

Fuchs Endothelial Corneal Dystrophy (FECD) Market is estimated at a market value of US$ 180 Billion by 2033

A recently published study by FMI expects the global Fuchs Endothelial Corneal Dystrophy (FECD) market to augment at a 7.5% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 370 Billion is expected for the market. The primary variables impacting the market growth rate include an increase …

Eosinophilic Esophagitis Market is expected to reach valuation of US$ 2032.8 Billion by 2033

The global demand for Eosinophilic Esophagitis is projected to increase at a CAGR of 28% during the forecast period between 2023 and 2033, reaching a total of US$ 2,032.8 Billion in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2023, sales witnessed significant growth, registering a CAGR of 23%. The …

Medical Terahertz Technology Market expected to reach US$ 768.05 Million by 2032

According to a report published by FMI, the global medical terahertz technology market will be valued at US$ 135.29 Million in 2022. It is expected to grow at a CAGR of 17.1% during the forecast period, reaching a value of US$ 768.05 Million by 2032. A fast-growing field of terahertz technology is driving market growth within the pharmaceutical industry because of its applications …

Aesthetic Medical Devices Market to expand at a 9.6% value CAGR by 2032

A recently published study by FMI expects the global aesthetic medical devices market to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly …

Surgical Drainage Devices Market is projected to reach a valuation of US$ 2.9 Billion by 2032

Global Surgical Drainage Devices Market was valued at US$ 1.3 Billion in 2021 and is expected to reach US$ 2.9 Billion by 2032, finds Future Market Insights (FMI) in a recent market survey. The growth of the market for Active Drains is projected to expand at a CAGR of around 7.8% during 2022 to 2032. The value …

Medical Automation Market is expected to garner a value of US$ 102.4 billion by 2033

The global medical automation market is expected to surpass an impressive USD 44.45 billion in 2022, with a compound annual growth rate (CAGR) of 10.6% from 2023 to 2033. The adoption of automated instruments by pharmaceutical companies’ drug discovery departments, the rise in demand for miniaturisation, and technological advancements combined with the rise in demand …

Vulvovaginal Candidiasis Treatment Market is anticipated to reach US$ 1607 Million by 2033

The global vulvovaginal candidiasis treatment market is currently valued at US$ 1035 million in 2023, with a CAGR of 4.5% expected. Because of technological advancements in the healthcare sector, the market is expected to reach US$1607 million by 2033. Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15875 Individuals’ VVC prevalence has increased due to an increase in …

Babesiosis Treatment Market is expected to reach US$ 1.98 Billion by 2033

In 2023, the global Babesiosis Treatment market is expected to be worth US$ 1.21 billion. With continuous advancements in drugs and biotechnology for the treatment of babesiosis, the overall scope for the Babesiosis Treatment Market is expected to grow at a CAGR of 5.0% between 2023 and 2033, totaling approximately US$ 1.98 Billion by 2033. …